跳至主要内容
临床试验/CTRI/2019/08/020875
CTRI/2019/08/020875Other未知

A Pilot project for assessment of safety and efficacy of miltefossine in the treatment of Acanthamoeba Keratitis

V Prasad Eye Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age equal to or more than 18 years.
  • 2) Male or female
  • 3) Stromal infiltrate size between <6 mm and involving anterior to mid stroma only.
  • 4) Corneal scraping positive for Acanthamoeba cysts in direct smear examination by any one or more of the methods used.

排除标准

  • 1) The corneal scrapings are negative for Acanthamoeba.
  • 2)The patient has a history of allergy to Miltefosine
  • 3) The cornea or sclera has been perforated or perforation is impending.
  • 4)The unaffected eye is legally blind. .
  • 5)The patient is known to be HIV positive or diabetic.
  • 6)The initial culture shows significant growth of bacteria ( >10 colonies) or fungus.
  • 7)Both eyes are infected.

研究者

发起方
V Prasad Eye Institute

相似试验